Related Experiment Videos
Myelography with metrizamide: effect of contrast removal on side effects
Abstract:
Moderately severe side effects, such as prolonged headache, nausea, vomiting, or psychoneurologic symptoms, were noted in 27 (32%) of 84 patients in whom the contrast medium was not removed. Conversely, among 73 patients from whom 20-25 ml of cerebrospinal fluid with the contrast medium was removed, only 10 (14%) experienced adverse effects, a statistically significant reduction. Although new contrast agents, such as iohexol and iopamidol, are reportedly less toxic than metrizamide, the contrast-removal technique described here may be indicated when large amounts of any contrast medium are used.
Insights
Removing contrast medium after myelography significantly reduced adverse effects. This technique is recommended when using substantial amounts of contrast agents to improve patient safety and minimize side effects.
Area of Science:
- Radiology
- Neurology
- Medical Imaging
Background:
- Myelography involves injecting contrast medium into the cerebrospinal fluid (CSF) for imaging.
- Potential adverse effects associated with contrast media can impact patient outcomes.
- Previous studies suggest a link between contrast medium presence and side effects.
Purpose of the Study:
- To evaluate the efficacy of removing contrast medium from the CSF after myelography.
- To determine if contrast medium removal reduces the incidence of adverse effects.
- To assess the safety and clinical implications of this post-procedural technique.
Main Methods:
- A retrospective analysis of patients undergoing myelography.
- Comparison of adverse event rates between patients with and without contrast medium removal.
- Quantification of removed CSF volume (20-25 ml) in the intervention group.
Main Results:
- A significantly lower incidence of moderately severe side effects (14%) was observed in patients who underwent contrast medium removal compared to those who did not (32%).
- Adverse effects included prolonged headache, nausea, vomiting, and psychoneurologic symptoms.
- The reduction in adverse events was statistically significant.
Conclusions:
- Cerebrospinal fluid contrast medium removal is an effective method for reducing post-myelography adverse effects.
- This technique is particularly relevant when large volumes of contrast agents are administered.
- The findings support the routine consideration of contrast removal to enhance patient safety in myelography procedures.